A clinical-stage biotechnology company focused on developing therapies targeting dermatological and gastrointestinal conditions, with research historically centered on microbiome-based treatments and topical drug formulations. The company operates with limited commercial revenue and is primarily dri...
No congressional trades have been disclosed for PRAXEUS BATS - ADR NEW (BERCE) (BPRM) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.